Show source-provided references
1. Ghebre-Selassie, I., and Martin, C. (2003). Pharmaceutical Extrusion Technology, Taylor & Francis.
10.1201/9780203911532 ↗2. Partheniadis, I., Gkogkou, P., Kantiranis, N., and Nikolakakis, I. (2019). Modulation of the Release of a Non-Interacting Low Solubility Drug from Chitosan Pellets Using Different Pellet Size, Composition and Numerical Optimization. Pharmaceutics, 11.
10.3390/pharmaceutics11040175 ↗3. Preparation and Characterization of Pellets Containing a Non-steroidal Antiinflamatory Drug, Coated with an Enteric Polymer
4. The Study of Piroxicam Dissolution from Eudragit RS-Coated Pellets
5. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets
10.1016/j.ijpharm.2006.05.011 ↗7. Preparation and in vitro Characterization of Pellets Containing Felodipine Solid Dispersions
12. Theismann, E.M., Keppler, J.K., Owen, M., Schwarz, K., and Schlindwein, W. (2019). Modelling the Effect of Process Parameters on the Wet Extrusion and Spheronisation of High-Loaded Nicotinamide Pellets Using a Quality by Design Approach. Pharmaceutics, 11.
10.3390/pharmaceutics11040154 ↗13. Tramadol SR formulations: Pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)
15. Pelletization process and techniques
17. Sarkar, S., Liew, C.V., Soh, J.L.P., Heng, P.W.S., and Wong, T.W. (2017). Microcrystalline cellulose: An overview. Functional Polymeric Composites, Apple Academic Press.
10.1201/9781315207452-3 ↗18. Swarbrick, J., and Boylan, J.C. (2002). Extrusion and extruders. Encyclopedia of Pharmaceutical Technology, Marcel Dekker Inc.
19. Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization
10.1023/A:1016237509740 ↗21. Al-Hashimi, N., Begg, N., Alany, R.G., Hassanin, H., and Elshaer, A. (2018). Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles. Pharmaceutics, 10.
10.3390/pharmaceutics10040176 ↗22. Wan, D., Zhao, M., Zhang, J., and Luan, L. (2019). Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer. Pharmaceutics, 11.
10.3390/pharmaceutics11060260 ↗23. Lin, H., Zhang, Z., Markl, D., Zeitler, J.A., and Shen, Y. (2018). A Review of the Applications of OCT for Analysing Pharmaceutical Film Coatings. Appl. Sci., 8.
10.3390/app8122700 ↗25. Yang, Q., Yuan, F., Xu, L., Yan, Q., Yang, Y., Wu, D., Guo, F., and Yang, G. (2019). An update of moisture barrier coating for drug delivery. Pharmaceutics, 11.
10.3390/pharmaceutics11090436 ↗28. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
10.1023/A:1016212804288 ↗29. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls
10.1208/s12248-015-9743-7 ↗32. Sustained release and enteric coated NSAIDs: Are they really GI safe?
33. Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (macaca fascicularis)
34. Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effect
10.1016/j.ijbiomac.2018.08.140 ↗36. Effect of different production variables on the physical properties of pellets prepared by extrusion-spheronization using a multivariate analysis
38. (2020, March 10). ImageJ Website–NIH, Available online: https://imagej.nih.gov/ij/plugins/circularity.html.
39. Fahr, A. (2018). Test Methods for Powders and Granules. Voigt’s Pharmaceutical Technology, John Wiley & Sons Ltd.
40. Development of Enteric Coated Pantoprazole Tablets with an Aqueous Based Polymer
41. Development of salbutamol sulphate sustained release pellets using acrylic polymer and polyvinyl acetate polymer and evaluation of in vitro release kinetics
10.3329/dujps.v9i2.7895 ↗43. Manda, A., Walker, R.B., and Khamanga, S.M.M. (2019). An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System. Pharmaceutics, 11.
10.3390/pharmaceutics11030109 ↗44. USP 38-NF 33 (2015). The United States Pharmacopeia 38-the National Formulary 33, United States Pharmacopeial Convention Inc.
45. Mircioiu, C., Voicu, V., Anuta, V., Tudose, A., Celia, C., Paolino, D., Fresta, M., Sandulovici, R., and Mircioiu, I. (2019). Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics., 11.
10.3390/pharmaceutics11030140 ↗47. Research concerning the development of a biorelevant dissolution test for formulations containing norfloxacin. I. Modelling of in vitro release kinetics
50. Evaluating bioequivalence of meloxicam tablets: Is in-vitro dissolution test overdiscriminating?
10.1111/jphp.12859 ↗52. (2020, March 11). FDA—Dissolution Methods Database, Available online: https://www.accessdata.fda.gov/scripts/CDER/dissolution/dsp_SearchResults.cfm.